Pharmabiz

Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study

Roche announced three-year follow-up data from the pivotal phase III STARGLO study in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who have received at least one ...
Pharmabiz

Kiran Mazumdar-Shaw honoured with ‘USC Business Management Award’ for her contributions in global healthcare and biotechnology

Kiran Mazumdar-Shaw, founder and chairperson, Biocon Group has been honoured with the USC Business Management Award, at the inaugural University of Southern California (USC) India Awards. She received ...
Pharmabiz

Abbott announces Lingo, an OTC continuous glucose monitor and app, now available on Android devices

Abbott announces Lingo, an OTC continuous glucose monitor and app, now available on Android devices: Abbott Park, Illinois Wednesday, December 10, 2025, 17:00 Hrs [IST] Abbott ann ...
Pharmabiz

India to co-host 2nd WHO Global Summit on Traditional Medicine in New Delhi

India to co-host 2nd WHO Global Summit on Traditional Medicine in New Delhi: Our Bureau, New Delhi Wednesday, December 10, 2025, 16:45 Hrs [IST] Union Ministry of Ayush has announ ...
Pharmabiz

US FDA approves Gamida Cell’s Omisirge, first cellular therapy to treat patients with severe aplastic anaemia

The US Food and Drug Administration (FDA) has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplant (HSCT) therapy to treat patients with severe aplastic anaemia (SAA).
Pharmabiz

Ceiling Price fixation or revision resulted in annual savings of Rs. 3,800 crore, says minister

Ceiling Price fixation or revision resulted in annual savings of Rs. 3,800 crore, says minister: Our Bureau, New Delhi Wednesday, December 10, 2025, 15:30 Hrs [IST] The National P ...
Pharmabiz

Researchers find genetic basis for important risk factor in blinding eye disease

Researchers find genetic basis for important risk factor in blinding eye disease: Bethesda, Maryland Wednesday, December 10, 2025, 15:30 Hrs [IST] A study funded in part by the Na ...
Pharmabiz

Zydus and Formycon partner for licensing and supply of biosimilar to Keytruda in US and Canada

Zydus and Formycon partner for licensing and supply of biosimilar to Keytruda in US and Canada: Our Bureau, Mumbai Wednesday, December 10, 2025, 15:20 Hrs [IST] Zydus Lifesciences ...
Pharmabiz

Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark

Roche introduces new PCR test to help improve diagnostic accuracy for women affected by vaginitis in countries following the CE Mark: Basel Wednesday, December 10, 2025, 15:00 Hrs ...
Pharmabiz

EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide

EpiVax and US FDA scientists publish new insights on immunogenicity risks of peptide-related impurities in generic teriparatide: Providence, Rhode Island Wednesday, December 10, 2 ...
Pharmabiz

Johns Hopkins University with Great Learning to launch AI in healthcare programme

Johns Hopkins University with Great Learning to launch AI in healthcare programme: Our Bureau, Bengaluru Wednesday, December 10, 2025, 13:45 Hrs [IST] Great Learning, a leading gl ...
Pharmabiz

Zydus introduces biosimilar denosumab 120 mg SC – protecting bone health in cancer patients

Zydus introduces biosimilar denosumab 120 mg SC – protecting bone health in cancer patients: Our Bureau, Mumbai Wednesday, December 10, 2025, 13:30 Hrs [IST] Zydus Lifesciences ...